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A B S T R A C T
The most common organisms causing prosthetic knee joint infections are staphylococci. However,
arthroplasty infections with atypical microbial pathogens, such as Mycobacteria can occur. Due to the
rarity of mycobacterial prosthetic joint infections, diagnosis, treatment, and management of these
atypical infections represent a clinical challenge. A 71-year old female post-operative day 40 after a left
total knee arthroplastywas hospitalized secondary to left knee pain and suspected arthroplasty infection.
She had failed outpatient oral antimicrobial treatment for superﬁcial stitch abscess; and outpatient IV/
Oral antimicrobials for a clinical postoperative septic bursitis. Ultimately, resection arthroplasty with
operative tissue acid fast bacterial cultures demonstrated growth of theMycobacterium smegmatis group.
Post-operatively, she completed a combination course of oral doxycycline and levoﬂoxacin and
successfully completed a replacement arthroplastywith clinical andmicrobial resolution of the infection.
To our knowledge, literature review demonstrates three case of knee arthroplasty infection caused by the
Mycobacterium smegmatis group. Correspondingly, optimal surgical procedures and antimicrobial
management including antimicrobial selection, treatment duration are not well deﬁned. Presently, the
best treatment options consists of two step surgicalmanagement including prosthesis hardware removal
followed by extended antimicrobial therapy, followed by consideration for re-implantation arthroplasty.
Our case illustrates importance of considering atypical mycobacterial infections in post-operative
arthroplasty infections not responding to traditional surgical manipulations and antimicrobials. For an
arthroplasty infection involving the atypical Mycobacterium smegmatis group, two step arthroplasty
revision, including arthroplasty resection, with a combination of oral doxycycline and levoﬂoxacin can
lead to successful infection resolution, allowing for a successful replacement arthroplasty.
ã 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Introduction
Total knee arthroplasty is a common orthopedic surgery
performed with an estimated of about six-hundred thousand
procedures done annually in the United States [1]. Infection rate is
less than 2% [1] but it is one of the leading causes of prosthetic joint
failure. Some of the risk factors for deep site infection after total
knee arthroplasty include body mass index (BMI) of greater than
35 (kg/m2), diabetes mellitus, male sex, a diagnosis of osteonec-
rosis, an American Society of Anesthesiologists (ASA) score of 3,
and a diagnosis of posttraumatic arthritis [2].
Microbiologically, septic arthroplasty infections can be catego-
rized into “typical” pathogens, those found with “routine” culture
techniques, and “atypical” those that require special culture
techniques include mycobacteria, fungi, mycoplasma, Nocardia,
and Actinomyces. Both early and late (Greater than 12 months)
infections in knee arthroplasty are primarily caused by relatively
virulent pathogens. More common pathogens in prosthetic joint
infection include Staphylococcus aureus (22%), polymicrobial (19%),
coagulase-negative staphylococcus (19%), beta-hemolytic strepto-
cocci (9%), aerobic Gram-negative bacilli (8%), anaerobes (6%),
negative culture (12%), and other organisms (5%) such as
Enterococcus, Corynebacterium, Listeria, Brucella, and Mycobacteri-
um tuberculosis [3].
There are typical and so called atypical mycobacteria, the latter
now called non-tuberculous mycobacteria. “Typical”- Mycobacte-
rium tuberculosis is the most common cause of human infection
worldwide. There are four groups of non-tuberculous mycobac-
teria which was originally classiﬁed by Runyon based in part on
pigment formation and rate of growth. Types IV are called rapidly
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growingmycobacteria (RGM) [4]. RGM [38_TD$DIFF]are foundmostly in soil and
water and are resistant to common disinfectant agents [5].
Infection in patients with prosthetic hip joints have been reported
[6]. RGM [39_TD$DIFF]are not easy to treat secondary to high antimicrobial-
resistance. We report a case of successfully treated prosthetic knee
joint infection caused by the rapidly growing Mycobacterium
smegmatis group.
Case report
A 71-year old immunocompetent female, with past medical
history of osteoarthrosis, chronic obstructive lung disease, chronic
kidney disease, hypertension, and nephrolithiasis, presented with
postoperative left arthroplasty knee pain. The patient was 40days
post-operative from an uncomplicated left total knee arthroplasty.
Approximately, one week prior to admission, she was treated
outpatient with oral sulfamethoxazole/trimethoprim DS as a
superﬁcial incisional stitch abscess, which involved the proximal
aspect of the linear arthroplasty incision. Clinical follow-up
demonstrated persistence and increasing peri-incisional soft
tissues edema and erythema, progressively extending along the
incisional line, and peri-incisional soft tissues. This, in spite of the
oral antimicrobials, raised concern for an associated septic bursitis.
Upon hospital admission, empiric intravenous vancomycin and
ampicillin-sulbactam were initiated for broad antibacterial cover-
age of gram negative and positive bacteria, including potential
methicillin sensitive andmethicillin resistant pathogens, targeting
a pre-patellar septic bursal infection.
Laboratory analysis revealed normocytic normochromic ane-
mia (Hemoglobin 10.2 g/dL); normalWhite count (10,000 per cubic
millimeter); [40_TD$DIFF]thrombocytosis (716,000 per cubic millimeter);
elevated C-reactive protein (7.5mg/dL); elevated Westergren
sedimentation rate (>140mm/h); negative HIV I & II; negative
QuantiFERON-TB Gold; non-reactive treponemal and hepatitis C
antibody. She presented with acute renal failure (Creatinine
2.3mg/dL: her baseline is 1.73mg/dL), BUN 28.2mg/dL. Gram
stain [41_TD$DIFF]revealed many polymorphonuclear leukocytes and few
Gram-positive bacilli.
Bedside tissue debridement was performed without ﬁndings of
an associated joint effusion. Routine tissue bacterial cultures
demonstrating an unidentiﬁable, slow-growing, aerobic Gram-
positive bacilli. A Peripherally Inserted Central Catheter (PICC) line
was placed, and she was discharged home targeting a four week
therapeutic course of empiric intravenous vancomycin. Unfortu-
nately, local peri-patellar swelling persisted, prompting a repeat
outpatient clinic arthrocentesis. Routine bacterial cultures, again,
revealed the slow growing, aerobic Gram-positive bacilli.
The repeated joint and tissue recovery of an unidentiﬁable, slow
growing, aerobic Gram-positive bacilli, raised the possibility of an
atypical microbial pathogen. A therapeutic decision was made to
electively perform intraoperative debridement of the joint and
bursa, and possible explantation of the arthroplasty hardware, and
to include repeat cultures to rule out typical and/or atypical
microbial infection, including AFB and fungi. Successful resection
of the knee arthroplasty was completed, with the insertion of
antimicrobial impregnated (vancomycin) cement. She was dis-
charged home on oral levoﬂoxacin and intravenous ampicillin-
sulbactam for a planned six weeks antimicrobial course awaiting
ﬁnal culture results.
Multiple cultures of the operative specimen were sent to
specialty lab for Acid-Fast bacterial smear and culture, and
ultimately Mycobacterium smegmatis group was identiﬁed from
several tissue cultures sent. The speciﬁc species within the group
was not identiﬁed. Antimicrobial susceptibility is listed in Table 1.
Antimicrobials were adjusted to include oral doxycycline and
levoﬂoxacin targeting a 6–12 months course of preoperative
antimicrobial therapy (Two step arthroplasty revision). Patient
completed a 10 months antimicrobial course, noting that
antimicrobial therapy was complicated by [42_TD$DIFF]a transient doxycycline
photosensitivity reaction.
Several weeks’ preoperative, repeat joint ﬂuid analysis was
negative for microbial growth, including AFB. A successful revision
knee arthroplasty was completed; and operative [43_TD$DIFF]cultures and joint
ﬂuid analysis, remained negative for ongoing infection. She was
maintained on the same antimicrobial combination of oral
doxycycline and levoﬂoxacin for 30days post-operative. Patient
tolerated the therapywell; [44_TD$DIFF]with a 10-month post-operative follow-
up, there has been no infection relapse.
Discussion
There are three groups of rapidly growingmycobacteria that are
known to cause human infection: M. fortuitum, M. chelonae/
abscessus, and the M. smegmatis group [7]. The M. fortuitum group
accounts for most cases of postsurgical wound and catheter
infection caused by RGM [7]. M. chelonae/abscessus is responsible
for most cases of disseminated cutaneous infections caused by
RGM in the community. In health care settings, it has been reported
as a cause of postsurgical wound infection in a variety of
procedures especially plastic surgery.
There are currently three species under theM. smegmatis group:
M. smegmatis sensu stricto. wolinskyi and M. goodi [7]. Pneumonia
as a rare cause ofM. smegmatis has been reported [8]. In the health
care setting, M. smegmatis has been reported in cases of catheter-
related infection, sternal wound infection with osteomyelitis post
cardiac surgery, and plastic surgery infection [7]. To our
knowledge, there have been three cases of prosthetic knee joint
infection caused by theM. smegmatis group. One case caused byM.
goodi was successfully treated with resection arthroplasty and a
combination of minocycline and ciproﬂoxacin for 6 months [9]. In
2008 another case reported, M. goodi was the culprit organism as
well. This patient did not undergo resection arthroplasty and was
treated with moxiﬂoxacin and doxycycline for 9 months followed
by doxycycline which was recommended for the life of the
prosthesis [10]. Eid et al. reported eighteen cases of prosthetic joint
infection caused by the rapidly growing mycobacterium. M.
Smegmatis was responsible for only one of the cases which was
successfully treated with resection arthroplasty and the following
antimicrobials combination: Doxycycline plus amikacin for two
weeks, then ciproﬂoxacin plus Sulfamethoxazole/Trimethoprim
for 16 weeks, meropenum plus ciproﬂoxacin for 4 weeks, and
ciproﬂoxacin for six weeks after reimplantation [6].
Our patient was ultimately diagnosed withM. smegmatis group
post-operative arthroplasty infection when repeat “routine” joint
ﬂuid and tissue cultures, demonstrated an unidentiﬁable, slow
growing, aerobic Gram-positive bacilli – characteristic Gram stain
of many AFB. When the organism was recovered, the paucity of
Table 1
Antimicrobial susceptibility of Mycobacterium Smegmatis.a
Antimicrobial agents MIC (ug/mL) Resistance
Amikacin 1 Susceptible
Cefoxitin 128 Resistant
Doxycycline 0.12 Susceptible
Minocycline 1 Susceptible
Trimethoprim/Sulfamethoxazole 0.25/4.8 Susceptible
Imipenem 4 Susceptible
Ciproﬂoxacin 0.25 Susceptible
Clarithromycin 16 Resistant
Linezolid 1 Susceptible
Moxiﬂoxacin 0.25 Susceptible
a ARUP National Reference Laboratories. 500 Chipeta Way, Salt Lake City, Utah
84108.
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information guiding the type and duration of antimicrobials to
treat this infection became problematic. Non-tuberculous myco-
bacterial infections are treated for prolonged periods [6].
Therefore, selection of antimicrobial duration was arbitrary set
at 6–12 months. At ten months post arthroplasty resection, joint
ﬂuid analysis was benign (Ultimately culture negative) and the
decision to proceedwith the second step arthroplasty replacement
was made. Post-operative antimicrobials were maintained until
cultures were considered sterile. Patient tolerated the antimicro-
bial therapy well; and as previously noted with [45_TD$DIFF]a 10-month post-
operative follow-up, there was no infection relapse.
The mode of acquisition of M. smegmatis infection for our
patient remains unknown. Although, as previously discussed, M
smegmatis skin and soft tissue infections have been reported as
post-operative surgical site infections and in immunocompro-
mised hosts [7,11]. Epidemiological investigation by the primary
surgical hospital’s Infection Control Department, did not identify a
point source of infection (for this environmental organism), nor
were any other additional temporally related institutional acquired
infection cases, medical or surgical, identiﬁed.
In conclusion, prosthetic knee joint infection due to a rapidly
growing mycobacterium identiﬁed as M. smegmatis have been
reported. A clinical suspicion for an atypical microbial infection,
including mycobacteria, should be included in the work up of any
post-operative arthroplasty infection. Obtaining Acid-Fast Bacte-
rial smears and cultures, in addition to “routine” Gram stain and
culture should be consider as part of the culturing process. Due to
the rarity of these organisms causing prosthetic knee arthroplasty
infections, management and treatment represent a clinical
challenge. For arthroplasty infections caused by rapidly growing
mycobacteria (Including M. smegmatis group), there are no
controlled trials or published treatment guidelines guiding
therapy. Literature review suggests successful treatment of these
types of infections include prosthesis removal, followed by
prolonged, but unspeciﬁed duration of antimicrobial therapy,
guided by known or published antimicrobial susceptibility
patterns. Our case illustrates the importance of considering an
atypical microbial infection, including mycobacteria, in suspected
septic knee arthroplasty infections that appear not responding to
traditional therapy.
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